Nirdesh Gupta
Angel Investor @ Cedars-Sinai Accelerator
Nirdesh Gupta is a seed investor at Cedars-Sinai Accelerator focused on Health Care and Medical. Nirdesh Gupta
- Total investments:
- 12
- Last investment:
- Lead investor:
- 75%
Last updated:
For AI agents: llms.txt
Industries Nirdesh Gupta invests in
Stages Nirdesh Gupta invests in
Countries Nirdesh Gupta invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 8 (67%)
- Medical 3 (25%)
- Medical Device 3 (25%)
- Machine Learning 3 (25%)
- Health Diagnostics 3 (25%)
Stage
- Seed 9 (75%)
- Pre-Seed 1 (8%)
- Series A 1 (8%)
Country
- United States 6 (50%)
- Singapore 2 (17%)
- United Kingdom 2 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Vivid Dx is a diagnostics company that focuses on pathogen detection and antimicrobial resistance testing services. | $15M / Seed / Jul 28, 2026 | ||
| Veritas Aortic Solutions manufactures medical equipments that helps with complicated aortic diseases. | $12M / Seed / Jun 01, 2026 | ||
| Kneu Health transforms smart phones into clinical-grade monitors to keep a tab on neurological conditions like Parkinson’s and dementia. | $5.6M / Seed / Oct 09, 2025 | ||
| Pulse Charter Connect provides organ transportation logistics services. | $2M / Seed / May 06, 2025 | ||
| Aevice Health provides non-invasive wearable technology that enables real-time monitoring of respiratory health. The devices facilitate early detection of cardiopulmonary issues and allow clinicians to track patient responses to treatment effectively. This approach enhances patient care by delivering critical insights directly from home. | $7M / Seed / Aug 09, 2024 | ||
| Pulse Charter Connect provides organ transportation logistics services. | $100K / Seed / Aug 01, 2024 | ||
| NOMA AI develops clinical decision support and patient monitoring and alerting solutions to prevent adverse medical events and improve clinical work-flows.NOMA AI uses machine learning and AI to process patients’ clinical data and treatment plans to build intelligent clinical decision support and patient monitoring and alerting solutions thatprovide informative and actionable insights to medical teams. | $100K / Seed / Aug 01, 2024 | ||
| Kinexcs is a data-driven digital health company enabling personalized health for fitness seekers and athletes & evidence-based recovery for musculoskeletal patients. | $100K / Seed / Aug 01, 2024 | ||
| Elaborate is a clinical intelligence platform that eliminates physician burnout by automating inbasket tasks. Using patient's own health data, it streamlines workflows for results management, referral processing, and visit preparation, freeing clinicians of time-consuming administrative work. Trusted by health systems, academic medicalcenters, and multi-specialty groups, Elaborate decreases administrative burden, enhances compliance, and improves patient communication. | $100K / Seed / Aug 01, 2024 | ||
| Engine Biosciences is a biotech company that applies machine learning to genomics for drug discovery.Engine Biosciences is a venture-backed San Francisco- and Asia-based technology company pioneering network biomedicine. The company's proprietary and patented technologies oriented around deciphering the complexity of biology networks includeboth high-throughput wet lab experimentation and artificial intelligence algorithms for drug discovery and cellular reprogramming. This platform, developed through several years of research by our scientific founding and leadership team who include faculty members at MIT, Harvard, Mayo Clinic, and UCSD, dramatically accelerates and reduces costs of the R&D process for new medical therapies. We are actively applying the platform internally and with partners across a range of disease indications. | $27M / Series A / Oct 31, 2023 | ||
| See all 12 investments → | |||
Co-Investors
About Cedars-Sinai Accelerator
The Cedars-Sinai Accelerator is transforming healthcare quality, efficiency, and care delivery by helping entrepreneurs bring their innovative technology products to market. This three-month program, based in Los Angeles, California, provides companies with $100,000 in funding, mentorship from more than 300 leading clinicians and executives,access to Cedars-Sinai, and exposure to a broad network of entrepreneurs and investors. Since 2015, the accelerator has helped dozens of companies transform healthcare delivery and patient care. It helps technology innovators turn their ideas into breakthroughs that can improve the lives of patients around the world.
Cedars-Sinai Accelerator Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Anne Wellington
Managing Director
|
|||
Motz Feinberg
Vice President Supply Chain
|
|||
Samantha Shobash
Admin
|
|||
Suneet Paul
Mentor and Coach
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Nirdesh Gupta invest in?
Nirdesh Gupta invests primarily in Health Care, Medical and Medical Device startups, most often at Seed and Pre-Seed stage. Most of the 12 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Nirdesh Gupta?
Public channels for Nirdesh Gupta include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Nirdesh Gupta last invest?
The most recent investment recorded for Nirdesh Gupta closed in Jul 2026. Shizune tracks 12 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
